Clinical Trial Update: Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of capecitabine with weekly paclitaxel in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Breast Cancer, Neoplasm Metastasis | Phase 2 | Status: COMPLETED